Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Colorcon
McKinsey
Dow
Express Scripts

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Jiangsu Hansoh Pharm Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for JIANGSU HANSOH PHARM, and what generic and branded alternatives to JIANGSU HANSOH PHARM drugs are available?

JIANGSU HANSOH PHARM has three approved drugs.

There is one tentative approval on JIANGSU HANSOH PHARM drugs.

Summary for Jiangsu Hansoh Pharm
US Patents:0
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Jiangsu Hansoh Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jiangsu Hansoh Pharm GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 202485-002 May 7, 2013 AP RX No No   Start Trial   Start Trial
Jiangsu Hansoh Pharm OLANZAPINE olanzapine TABLET;ORAL 209399-002 Sep 24, 2018 AB RX No No   Start Trial   Start Trial
Jiangsu Hansoh Pharm VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 091106-001 Sep 26, 2012 AP RX No No   Start Trial   Start Trial
Jiangsu Hansoh Pharm OLANZAPINE olanzapine TABLET;ORAL 209399-003 Sep 24, 2018 AB RX No No   Start Trial   Start Trial
Jiangsu Hansoh Pharm GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 202485-001 May 7, 2013 AP RX No No   Start Trial   Start Trial
Jiangsu Hansoh Pharm OLANZAPINE olanzapine TABLET;ORAL 209399-001 Sep 24, 2018 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Dow
Express Scripts
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.